iiinova — where your digital self keeps evolving

Abbexa @abbexa.bsky.social · 06/07/2026

If your research focuses on zoonotic diseases, explore Abbexa's extensive product portfolio or get in touch to discuss bespoke solutions tailored to your needs.

000

Abbexa @abbexa.bsky.social · 06/07/2026

This World Zoonoses Day, we're highlighting a selection of Abbexa’s articles exploring the science behind some of the world's most significant infectious diseases, many of which begin with a jump from animals to humans: www.linkedin.com/feed/update/...

110

Abbexa @abbexa.bsky.social · 11/06/2026

With Ebola once again making headlines, we asked our scientist, Nick Thomas, to answer some of the most common questions about the virus. Read more: www.linkedin.com/feed/update/...

010

Abbexa @abbexa.bsky.social · 03/06/2026

Proteins and peptides are central to scientific discovery, driving progress across biology and medicine every day. For a limited time, Abbexa is offering 15% off selected proteins and peptides to support your research: www.abbexa.com/products/pro...

000

Abbexa @abbexa.bsky.social · 28/05/2026

Unlike other hantaviruses, the Andes virus is capable of spreading from person to person - a rare trait that has renewed global attention. But how does transmission happen, and why are scientists so concerned about this virus? Read more in Abbexa's recent article: www.abbexa.com/the-only-han...

abbexa.com

The Only Hantavirus Known for Human-to-Human Transmission: Andes Virus

000

Abbexa @abbexa.bsky.social · 26/05/2026

'The protocol was straightforward, the reagents were easy to prepare, and the results were consistent across samples.' — Researcher, UK Join researchers already achieving reliable results with Abbexa products and take advantage of 15% off discount before 31 May 2026: www.abbexa.com/products/eli...

000

Abbexa @abbexa.bsky.social · 12/05/2026

Meet Abbexa at the Institute of Metabolic Science on 21 May 2026! Come and discover our latest reagents, speak directly with our scientists, and pick up free Abbexa goodies (including our popular grey felt bags). 📍IMS Tea Room, Level 4, @ims-mrl.bsky.social 📅21 May 2026, 9:30 am – 4:00 pm

001

Abbexa @abbexa.bsky.social · 06/05/2026

Using Abbexa’s Taurine ELISA Kit, a research team from the University of California identified a compound that may affect taurine levels in mouse blood. Enhance your research with 15% off selected ELISA, CLIA, and primary antibodies before 31 May: www.abbexa.com/products/eli...

020

Abbexa @abbexa.bsky.social · 29/04/2026

Open role at Abbexa: Regulatory Affairs Officer This is a fantastic opportunity for a regulatory professional with strong experience in Medical Devices regulatory frameworks. Read more about the role and apply here: www.abbexa.com/regulatory-a...

010

Abbexa @abbexa.bsky.social · 28/04/2026

A smarter way to study treatment resistance in cancer is emerging through 3D spheroid models. Read a new article by Hailey Sze, PhD Researcher at @qmul.bsky.social, to explore how these models are transforming research into Head and Neck Squamous Cell Carcinoma: www.abbexa.com/a-smarter-wa...

abbexa.com

3D Spheroid Model: A Smarter Way to Study Treatment Resistance in Head and Neck Cancer

010

Abbexa @abbexa.bsky.social · 20/04/2026

Our first time at the Microbiology Society conference was a memorable one! So nice to meet so many microbiologists working on such impactful research. Huge thanks to everyone who supported us, and to the @microbiologysociety.org team for an excellent event. Hope to be back in 2027! #Microbio26

141

Abbexa @abbexa.bsky.social · 20/04/2026

Our team is at #AACR26, ready to talk to you about our ELISA kits, antibodies, proteins and peptides that can support your research in the fight against #cancer. Stop by stand #3452 and pick up one of our famous grey bags before they're gone!

The Abbexa Team stood in front of their booth at AACR, smiling. In the front is a large blue and yellow hexagon table. In the background, the booth reads Abbexa, Do Better Science and Custom & Niche Supplier.

000

Abbexa @abbexa.bsky.social · 14/04/2026

Rainy day in Belfast today but fear not, Abbexa still have a few umbrellas! If you’re in Belfast, come and say hello to our team at the Microbiology Society Annual Conference. We’ll be at stand 12 until Thursday, April 16. #Microbio26 #Microbiology #Abbexa @microbiologysociety.org

061

Abbexa @abbexa.bsky.social · 13/04/2026

Get 15% off some of our top-selling CLIA Kits: · Human Thyroglobulin (TG) CLIA Kit · Human Angiopoietin 1 (ANG1) CLIA Kit · Mouse Tumor Protein (TCTP1) CLIA Kit and more! 🔗 Offer ends on the 31st of May: www.abbexa.com/products/eli... #CLIAkit #ELISAkit

000

Abbexa @abbexa.bsky.social · 09/04/2026

Get high quality antibodies with 15% off, including products from Abbexa’s top 100 bestsellers list: 🔬 Mucin-21 (MUC21) Antibody 🔬 Defensin Alpha 5, Paneth Cell Specific (DEFA5) Antibody Explore all available products with 15% off: www.abbexa.com/products/eli... #ELISAkit #Antibody

000

Abbexa @abbexa.bsky.social · 08/04/2026

Our range of BRCA1 products features fully validated antibodies and top-rated ELISA kits that are designed to deliver reliable, reproducible results across a variety of sample types. See more of our cancer research essentials www.abbexa.com/products/ess...

000

Abbexa @abbexa.bsky.social · 08/04/2026

Known as a hereditary risk marker, BRCA1 safeguards our genome by promoting DNA repair, meaning that without this gene, tumour cells can grow more easily. Mutations in this gene are strongly associated with the development of breast cancer.

100

Abbexa @abbexa.bsky.social · 07/04/2026

One highlight from our Top-100 range is the Human Aspartoacylase (ASPA) ELISA Kit (Catalogue No: abx519903). It’s now available at 15% off. Discover the full promotion on our website and see which other ELISA, CLIA, and antibodies are included: www.abbexa.com/products/eli... #Abbexa #ELISAkit

000

Abbexa @abbexa.bsky.social · 02/04/2026

Get 15% Off Selected ELISA Kits, CLIA Kits, and Primary Antibodies: www.abbexa.com/products/eli... Offer ends 31 May 2026. Stock up today and keep your research moving.

000

Abbexa @abbexa.bsky.social · 31/03/2026

Curiosity drives scientific progress, and having specific, reliable tools helps researchers get clear, dependable results. With AACR on the horizon, we’re highlighting our range of cancer research essentials, featuring hundreds of cited products Our collection: www.abbexa.com/products/ess...

000

Abbexa @abbexa.bsky.social · 26/03/2026

As a result, a growing interest among researchers is the tumour microenvironment with a focus on Secreted Frizzled-Related Protein 2 (SFRP2). What does the use of SFRP2 mean for the future direction of therapeutic strategies in TNBC? Find out in our latest article. www.abbexa.com/The-Emergenc...

000

Abbexa @abbexa.bsky.social · 26/03/2026

Accounting for approximately 15% of breast cancer cases, Triple Negative Breast Cancer is one of the most difficult cancers to treat. This is due to the lack of hormonal and molecular markers targeted by modern therapies.

100

Abbexa @abbexa.bsky.social · 18/03/2026

Abbexa will be exhibiting at the Microbiology Society Annual Conference 2026, taking place from 13–16 April at the ICC Belfast. Come and meet our team to see how we can support your work in microbiology. And of course, our infamous grey felt bags and golf umbrellas will be there too! #Microbio26

010

Abbexa @abbexa.bsky.social · 17/03/2026

Reliable insights depend on reliable tools. Abbexa offers a wide catalogue of specific, fully validated antibodies designed to support consistent, trustworthy results, including our Mucin 21 (MUC21) Antibody. Explore our catalogue: www.abbexa.com/products

002

Abbexa @abbexa.bsky.social · 17/03/2026

MUC21 shows distinct expression in several tumour types, including lung adenocarcinoma, skin cancers, and brain tumours such as glioblastoma. This makes MUC21 a potential candidate for the diagnosis, treatment, and recovery outcomes, making it a key focus for ongoing oncology research.

101

Abbexa @abbexa.bsky.social · 17/03/2026

The Mucin 21 (MUC21) Antibody continues to gain attention in cancer research, and a 2024 study highlights why: researchers suggest that MUC21 may be a potential new target for tumour treatment.

100

Abbexa @abbexa.bsky.social · 13/03/2026

We were delighted to represent Abbexa at the Cambridge Biomedical Campus Careers Fair! It was great meeting so many talented people and discussing careers in life sciences. If you’d like to learn more about working at Abbexa, take a look at our careers page: www.abbexa.com/careers

001

Abbexa @abbexa.bsky.social · 12/03/2026

At Abbexa, we’re here to make that journey more efficient. Our custom multiplex kits enable you to detect multiple antigens, saving both time and precious sample volume. As researchers know, it’s rarely just one biomarker that tells the whole story. abbexa.com/custom-multi...

000

Abbexa @abbexa.bsky.social · 12/03/2026

Increasingly, researchers are turning to Multiplex Immunofluorescence (mIF) and Multiplex Immunohistochemistry (IHC) to uncover how specific immune cells interact with tumour cells, helping to sharpen clinical prognosis and improve treatment predictions.

100

Abbexa @abbexa.bsky.social · 12/03/2026

Understanding the complexity of the tumour microenvironment is essential for advancing cancer diagnostics and treatment.

100

Abbexa @abbexa.bsky.social · 04/03/2026

Meanwhile, UNC13C has been identified as an independent prognostic indicator for liver cancer (HCC), meaning that this protein might be a prognostic biomarker and therapeutic target in HCC.

000

Abbexa @abbexa.bsky.social · 04/03/2026

These proteins are recognised for their involvement in immune regulation and tumour biology. More specifically, UNC13D has a vital role in immune cell function response, meaning it can be used to prompt immune cells to react to cancerous cells, making it a focal point for immunology researchers.

110

Abbexa @abbexa.bsky.social · 04/03/2026

Recent research highlights the pivotal roles that members of the UNC13 family have been observed to play in various types of diseases, including different types of cancer.

100

Abbexa @abbexa.bsky.social · 26/02/2026

The team working on this project has managed to achieve tumour regression and prevent them from recurring using triple combination therapy. Could this breakthrough be the cornerstone of human treatment? Find out more: www.abbexa.com/Pancreatic-C...

000

Abbexa @abbexa.bsky.social · 26/02/2026

With a survival rate of only 13% across all stages, pancreatic cancer remains one of the deadliest cancers. However, the latest research has revealed that scientists have been able to cure pancreatic cancer in mice.

100

Abbexa @abbexa.bsky.social · 25/02/2026

Only 3 days left to save 20% on biosimilars If biosimilars are part of your research, now is the moment to optimise your budget without compromising on quality. Explore 600+ biosimilars at a reduced price: www.abbexa.com/products/bio... Orders must be placed before 28 February 2026. T&Cs apply.

000

Abbexa @abbexa.bsky.social · 17/02/2026

Book your time slot today: outlook.office.com/book/Abbexa....

000

Abbexa @abbexa.bsky.social · 17/02/2026

Being one of the largest and most influential research conferences in the world, AACR is a platform for researchers worlwide to share the latest breakthroughs driving us forward in the battle against cancer. Find our team at booth #3452 to discuss new insights to your research.

100

Abbexa @abbexa.bsky.social · 11/02/2026

On the International Day of Women and Girls in Science, women at Abbexa shared their science journeys and what inspired them. 🧪Read their stories here: bit.ly/4qvddAa #WomenInScience #Abbexa

020

Abbexa @abbexa.bsky.social · 04/02/2026

At Abbexa we're proud to support researchers working in niche areas of cancer research, because every story matters. World Cancer Day reminds us of those battling cancer. It is their stories and experiences that drive the dedicated researchers to develop new methods of treatment and prevention.

010

Abbexa @abbexa.bsky.social · 04/02/2026

With cancer influencing millions of lives in countless ways, behind every diagnosis is a unique story. Rare cancers make up for 30% of total cancer related deaths. The need for specialised research in these areas is vital to address the global burden of cancer.

110

Abbexa @abbexa.bsky.social · 27/01/2026

Get top-performing biosimilars with 20% off 🔬 Abbexa biosimilars deliver consistency, validated performance & expert scientific support at a lower cost. ⏳ Offer ends by the end of February: bit.ly/3O3S4iN #Biosimilars #LifeScienceResearch #Abbexa

010

Abbexa @abbexa.bsky.social · 21/01/2026

Our team has written an article exploring the science of aging, with a focus on how cellular senescence, chronic inflammation, and Immunosenescence contribute to degenerative conditions such as dementia. Read the full article here www.abbexa.com/the-science-...

010

Abbexa @abbexa.bsky.social · 21/01/2026

Between 2014 and 2024, the number of people living with dementia increased by 15%. #RaceAgainstDementiaDay is a reminder of the many lives affected by this condition. With age related diseases becoming more prevalent, high quality research is essential to improve long term health and longevity.

110

Abbexa @abbexa.bsky.social · 18/11/2025

Christmas has arrived in the lab🎄 Enjoy FREE shipping on all ELISA kits till the end of the year! 🎁 For full details, T&Cs, and upcoming content, head to our LinkedIn page: bit.ly/48422XU Start choosing your Christmas ELISA on our website: bit.ly/3LTQCyx

030

Abbexa @abbexa.bsky.social · 13/11/2025

World quality day reminds us that quality is the backbone of life science and biotechnology, to ensure reliable research outcomes. That’s why at Abbexa we take pride in maintaining our ISO 9001 certification. Access to our range of essential research tools: www.abbexa.com

020

Abbexa @abbexa.bsky.social · 11/11/2025

Reliable detection tools are essential for effective research and monitoring. Go into flu season prepared with Abbexa’s top-performing avian influenza assay kits this season: • H5 Virus Antigen Rapid Test Kit • H5 Virus Antibody (Anti-AIV-H5) ELISA Kit • H9 Virus Antibody (Anti-AIV-H9) ELISA Kit.

020

Abbexa @abbexa.bsky.social · 06/11/2025

Mpox remains a public health concern as all viral clades continue to circulate. 🔬 This month, we spotlight the Mpox B2R hemagglutinin protein, a key viral antigen: bit.ly/3JO1VaO We also offer up to 20% off 10,000+ proteins & peptides: bit.ly/485r8pB

010

Abbexa @abbexa.bsky.social · 31/10/2025

Are your suppliers as committed to sustainability as you are? Make your research more sustainable by choosing to switch to our new paperless option, allowing you to access your product manual through a QR code found within our packaging. Help us work towards a more sustainable future.

010

Abbexa @abbexa.bsky.social · 29/10/2025

Responsible research means high-quality outputs with less environmental impact. Our Paperless Manuals replace printed guides with QR codes, reducing paper and making your research easier and more sustainable. Learn more on our website: www.abbexa.com/scientific-s... #WorldSustainabilityDay #Abbexa

010